Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Public comment period · §3

Draft synthesis: Acute pancreatitis with incretin-based… — disposition

The disposition of every submission and the amendments that resulted.

Document identifier
CEI-CP-115/3
Series
Public comment period
Version
1.0
Published
04 Jan 2025
Last reviewed
04 Jan 2025
Next review
04 Jan 2026
Identifier
10.71829/cei.cp.115
Certainty
Not rated
Cycle
2024 Q4
Window
22 Oct 2024 – 17 Dec 2024
Status
Closed
Submissions
10

§3Disposition and amendments

§3.1Disposition table

Table 1. Every submission with its disposition. Each row links to the submission in full.

ReferenceRespondentPoint raisedDisposition
DRAFT-PANCREATITIS/002Dr Kamila Glendinning-UcheThe document is unreadable without specialist trainingAccepted in part
DRAFT-PANCREATITIS/001Zdenka XimenesBaseline imbalance in a small contributing trial is not remarked onNoted, no amendment
DRAFT-PANCREATITIS/008Dr Hamish Nyquist-ObioraThe review question is drawn too broadly to be answerableNot accepted
DRAFT-PANCREATITIS/005Ludmila BrackenridgeStatistical heterogeneity is treated as though it measured clinical heterogeneityAccepted in part
DRAFT-PANCREATITIS/007Dr Marisol Dunmore-Ekpo industryThe document should not describe uses outside the approved indicationNot accepted
DRAFT-PANCREATITIS/006Dr Fenella LavrentievAn indirect comparison is presented without an assessment of transitivityAccepted
DRAFT-PANCREATITIS/003Dr Wilhelmina WintringhamRisk-of-bias judgements are reported as an overall rating without the domainsAccepted
DRAFT-PANCREATITIS/010Dr Wilhelmina ErlingssonThe document set should be published in translationNot accepted
DRAFT-PANCREATITIS/004Dr Matthias Whitmarsh-ObiQuantitative claims are reproduced without the method that produced themAccepted
DRAFT-PANCREATITIS/009Dr Adaeze Dunmore-EkpoA superseded version should remain reachable from the version that replaced itNoted, no amendment
10 submissions in total.

§3.2Summary by disposition

Table 2. Counts by disposition, with the meaning of each.

DispositionCountMeaning
Accepted3The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Accepted in part2Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.
Noted, no amendment2The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Not accepted3The submission is not accepted. The secretariat response gives the reason. A submission that is not accepted remains published in full; the Institute does not remove a submission because it disagrees with it.

§3.3Resulting amendments

  1. The document is unreadable without specialist training — arising from DRAFT-PANCREATITIS/002. Every document now opens with a plain-language summary of not more than 150 words, placed above the technical abstract and carrying the same certainty language, so that the two cannot diverge.
  2. Statistical heterogeneity is treated as though it measured clinical heterogeneity — arising from DRAFT-PANCREATITIS/005. The decision to pool is now justified in prose against the population, intervention, comparator and outcome before any statistic is presented, and the heterogeneity statistic is reported with its confidence interval and a note of the number of contributing…
  3. An indirect comparison is presented without an assessment of transitivity — arising from DRAFT-PANCREATITIS/006. Transitivity is now assessed against a stated list of effect modifiers and reported before any indirect estimate, and where the assessment fails the contrast is reported as unestimable with the reason rather than estimated with a caveat.
  4. Risk-of-bias judgements are reported as an overall rating without the domains — arising from DRAFT-PANCREATITIS/003. Risk of bias is now reported at domain level for every included study, with the text on which each judgement was based quoted and referenced, and the overall judgement derived from the domains rather than asserted alongside them.
  5. Quantitative claims are reproduced without the method that produced them — arising from DRAFT-PANCREATITIS/004. Every quantitative claim now carries the determination that produced it at the point of use, and figures obtained by non-comparable methods are no longer presented in the same row or sentence.

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.